Ten‐day <i>versus</i> 14‐day vonoprazan‐amoxicillin high‐dose dual therapy for <i>Helicobacter pylori</i> eradication in China: A multicenter, open‐label, randomized study
Ten-day VA dual therapy achieves comparable efficacy and safety to the 14-day regimen in Chinese population, providing patients with greater convenience and economic benefits.
Authors
- Yijuan Liu (ORCID: https://orcid.org/0000-0002-2486-8037)
- Yanfeng Shao
- Weixing Lin (ORCID: https://orcid.org/0000-0001-6266-5292)
- L Chen
- Zhenqun Lin
- Zhonghua Huang (ORCID: https://orcid.org/0000-0002-2627-411X)
- Yongfu Wang (ORCID: https://orcid.org/0000-0003-3196-063X)
- Longqun Chen
- Feng Qiu (ORCID: https://orcid.org/0000-0002-1660-8307)
- Xueping Huang (ORCID: https://orcid.org/0000-0003-2803-2277)
- Shuo Chen (ORCID: https://orcid.org/0000-0001-7426-3493)
- Zhongqin Xiao
- Zhi Hui Lin (ORCID: https://orcid.org/0000-0002-2165-9280)
- Aiping Lin
- Zhangkun Xu
Institutions
- Fujian Medical University (CN)
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Fuzhou General Hospital of Nanjing Military Command (CN)
- First Affiliated Hospital of Fujian Medical University (CN)
- Fujian Provincial People's Hospital (CN)
- Fujian Provincial Hospital (CN)
- Putian University (CN)
Publication Details
- Journal
- Journal of Gastroenterology and Hepatology
- Published
- 2024-11-24
- DOI
- https://doi.org/10.1111/jgh.16761
- Citations
- 5
- Primary Topic
- Helicobacter pylori-related gastroenterology studies
- Type
- article
- Field-Weighted Citation Impact
- 2.86
Funders
- Natural Science Foundation of Fujian Province